General Information of This Metabolic Reaction (MR) (ID: MR001593)
Formula Reactant Lumiracoxib metabolite M8 Product Lumiracoxib metabolite M10
Reactant Info Product Info
Metabolic Enzyme UDP-glucuronosyltransferase 1A1 (UGT1A1) DME Info
Metabolic Type Conjugation - Glucuronidation
Other MR(s) Related to The Reactant of This MR
Other MR(s) That Produce The Reactant of This MR
MR ID Reactant Product MR Type Related Drug REF
MR001595 Lumiracoxib metabolite M15 Lumiracoxib metabolite M8 Oxidation - Hydroxylation Lumiracoxib [1]
MR001589 Lumiracoxib metabolite M5 Lumiracoxib metabolite M8 Oxidation - Hydroxylation Lumiracoxib [1]
MR001593 Lumiracoxib metabolite M8 Lumiracoxib metabolite M10 Conjugation - Glucuronidation Lumiracoxib [1]
Other MR(s) That Metabolize The Reactant of This MR
MR ID Reactant Product MR Type Related Drug REF
MR001591 Lumiracoxib metabolite M8 Lumiracoxib metabolite M12 Oxidation - Hydroxylation Lumiracoxib [1]
MR001592 Lumiracoxib metabolite M8 Lumiracoxib metabolite M4/metabolite M6 Unclear Lumiracoxib [1]
Other MR(s) Related to The Product of This MR
Other MR(s) That Produce The Product of This MR
MR ID Reactant Product MR Type Related Drug REF
MR001595 Lumiracoxib metabolite M15 Lumiracoxib metabolite M8 Oxidation - Hydroxylation Lumiracoxib [1]
MR001589 Lumiracoxib metabolite M5 Lumiracoxib metabolite M8 Oxidation - Hydroxylation Lumiracoxib [1]
Other MR(s) That Metabolize The Produtc of This MR
MR ID Reactant Product MR Type Related Drug REF
MR001593 Lumiracoxib metabolite M8 Lumiracoxib metabolite M10 Conjugation - Glucuronidation Lumiracoxib [1]
MR001591 Lumiracoxib metabolite M8 Lumiracoxib metabolite M12 Oxidation - Hydroxylation Lumiracoxib [1]
MR001592 Lumiracoxib metabolite M8 Lumiracoxib metabolite M4/metabolite M6 Unclear Lumiracoxib [1]
References
1 Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.